Sundrug Co Stock

Sundrug Co EBIT

The EBIT of Sundrug Co (9989.T) as of Aug 9, 2026 is 44.50 B JPY. In the previous year, EBIT was 41.00 B JPY — a change of 8.54% (higher).

EBIT

44.50 BJPY

YoY

8.54%

Last updated:

In 2026, Sundrug Co's EBIT was 44.50 B JPY, a 8.54% increase from the 41.00 B JPY EBIT recorded in the previous year.

The Sundrug Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B JPY)
Date
EBIT (B JPY)
Jan 1, 2024
41.00 base
Jan 1, 2025
44.50 base
Jan 1, 2026 (e)
47.25 base
Jan 1, 2027 (e)
50.39 base
Jan 1, 2028 (e)
53.18 base
Jan 1, 2029 (e)
55.12 base
Jan 1, 2030 (e)
57.03 base
Jan 1, 2031 (e)
59.63 base
YEAREBIT (B JPY)
2031 est 59.63
2030 est 57.03
2029 est 55.12
2028 est 53.18
2027 est 50.39
2026 est 47.25
2025 44.50
2024 41.00
2023 37.45
2022 34.05
2021 37.35
2020 36.60
2019 35.23
2018 36.08
2017 34.06
2016 33.03
2015 25.92
2014 28.06
2013 24.72
2012 22.26
2011 19.24
2010 16.03
2009 14.76
2008 13.92
2007 12.69
2006 12.26
Access this data via the Eulerpool API

Sundrug Co Revenue

Sundrug Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
751.78 B JPY
41.00 B JPY
29.13 B JPY
Jan 1, 2025
801.81 B JPY
44.50 B JPY
30.75 B JPY
Jan 1, 2026 (e)
841.98 B JPY
47.25 B JPY
31.40 B JPY
Jan 1, 2027 (e)
898.00 B JPY
50.39 B JPY
33.81 B JPY
Jan 1, 2028 (e)
947.75 B JPY
53.18 B JPY
36.26 B JPY
Jan 1, 2029 (e)
982.37 B JPY
55.12 B JPY
37.76 B JPY
Jan 1, 2030 (e)
1.02 T JPY
57.03 B JPY
37.64 B JPY
Jan 1, 2031 (e)
1.06 T JPY
59.63 B JPY
39.00 B JPY

Sundrug Co Margins

Sundrug Co stock margins

The Sundrug Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sundrug Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sundrug Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
25.18 %
5.45 %
3.87 %
Jan 1, 2025
25.45 %
5.55 %
3.84 %
Jan 1, 2026 (e)
25.45 %
5.61 %
3.73 %
Jan 1, 2027 (e)
25.45 %
5.61 %
3.77 %
Jan 1, 2028 (e)
25.45 %
5.61 %
3.83 %
Jan 1, 2029 (e)
25.45 %
5.61 %
3.84 %
Jan 1, 2030 (e)
25.45 %
5.61 %
3.70 %
Jan 1, 2031 (e)
25.45 %
5.61 %
3.67 %

Sundrug Co Stock analysis

What does Sundrug Co do? Sundrug Co Ltd is a Japanese company that was founded in Osaka in 1960. It started as a small pharmaceutical company that manufactured and sold over-the-counter medications and health products. Over the years, Sundrug has developed into a leading company in the Japanese health market. The business model of Sundrug is based on a comprehensive offering of health products and services. The company operates a variety of stores, including drugstores, pharmacies, supermarkets, and shopping centers, where it offers a wide range of products. The company is also involved in the manufacturing and marketing of pharmaceuticals and medical devices, and provides services such as health consultation and nursing care. One of the key divisions of Sundrug is its retail department, with its drugstores and pharmacies. Here, the company offers a wide range of over-the-counter medications, vitamins, and health products. The products range from cosmetic items to dietary supplements to enhance the well-being and health of customers. Another important division of Sundrug is the production of pharmaceutical products. The company manufactures a wide range of medications and medical devices, such as antibiotics, pain relievers, or diabetes medications. As part of its quality control, the company has a strict system for monitoring and testing its products. Sundrug is also active in the service industry and operates some hospitals and care facilities. The company offers consulting services and care services for elderly people. It operates as a non-profit organization and places great emphasis on promoting quality of life and health. The company also has a strong presence in the e-commerce sector. It operates an online platform where customers can conveniently order their health products from home. The company also offers a subscription service for regularly needed medications and products. Another important division of Sundrug is the cosmetic department. Here, the company offers a wide range of beauty products such as skin creams, shampoos, and makeup. The company follows the approach of meeting the needs of customers and offering products suitable for different age groups and skin types. Today, Sundrug is a leading company in the Japanese health market. Over the years, it has built a strong brand image and is known for its high-quality products and excellent services. The company places great emphasis on promoting health and well-being and strives to play a leading role in this market. Sundrug Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Sundrug Co's EBIT

Sundrug Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Sundrug Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Sundrug Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Sundrug Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Sundrug Co stock

EBIT of Sundrug Co is 44.50 B JPY in 2026.

EBIT of Sundrug Co changed from 41.00 B JPY to 44.50 B JPY, representing a 8.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Sundrug Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Sundrug Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Sundrug Co

All Key Metrics — Sundrug Co